Activist investor Ananym Capital Management is urging healthcare products distributor Henry Schein to refresh its board, cut ...
Henry Schein (NASDAQ:HSIC) advanced 5.3% following a 3.3% increase on Friday amid some speculation the dental products ...
Supported by world-class markets data from Dow Jones and FactSet, and partnering with Automated Insights, MarketWatch ...
The most recent earnings report from Henry Schein, Inc. (NASDAQ:HSIC) was disappointing for shareholders. However, our analysis suggests that the soft headline numbers are getting counterbalanced by ...
The 12-month price targets, analyzed by analysts, offer insights with an average target of $79.5, a high estimate of $82.00, ...
Nov 5 (Reuters) - Dental products distributor Henry Schein (HSIC.O), opens new tab beat third-quarter profit estimates on Tuesday, as a series of cost-saving measures helped counter tepid demand and ...
Henry Schein (HSIC – Research Report), the Healthcare sector company, was revisited by a Wall Street analyst today. Analyst Michael ...
Henry Schein (NASDAQ:HSIC) rose 7.4% amid a report that an activist investor has taken a stake and is pushing for the ...